On Sep 9, 2021 Solugen closed a Series C round and raised $350,000,000 from Baillie Gifford, BlackRock, Carbon Direct, Fifty Years, GIC, Refactor Capital, Temasek […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
Series A – Neuroglee Therapeutics
On Sep 9, 2021 Neuroglee Therapeutics closed a Series A round and raised $10,000,000 from EDBI, Eisai, Kuldeep Singh Rajput, Openspace Ventures, Raman Singh, Wendou […]
Series D – Mammoth Biosciences
On Sep 9, 2021 Mammoth Biosciences closed a Series D round and raised $150,000,000 from Decheng Capital, Foresite Capital, Greenspring Associates, Mayfield Fund, NFX, Plum […]
Series A – PhableCare
On Sep 9, 2021 PhableCare closed a Series A round and raised ₹140,000,000 from Omron Ventures, featuring lead investors Omron Ventures. About the company: PhableCare […]
Seed Round – Grouport
On Sep 9, 2021 Grouport closed a Seed round and raised $1,500,000 from 380 Cap, XV Venture Capital, featuring lead investors XV Venture Capital. About […]
Series A – DotCom Therapy
On Sep 9, 2021 DotCom Therapy closed a Series A round and raised $8,750,000 from LRVHealth, New Capital Partners, OSF Ventures, featuring lead investors New […]
Series A – Blue Note Therapeutics
On Sep 9, 2021 Blue Note Therapeutics closed a Series A round and raised $5,200,000 from Alumni Ventures Group, Jazz Venture Partners, Memorial Sloan – […]
Series B – Lycia Therapeutics
On Sep 9, 2021 Lycia Therapeutics closed a Series B round and raised $70,000,000 from Alexandria Venture Investments, Cowen Healthcare Investments, Eli Lilly, Invus, Redmile […]
Series G – RareCyte
On Sep 9, 2021 RareCyte closed a Series G round and raised $24,000,000 from 5AM Ventures, Agilent Technologies, Arboretum Ventures, F-Prime Capital, HealthQuest Capital, Logos […]
